Farwa Nisa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Farwa Nisa has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Afridi
Department of Medicine, Khyber Medical College, Peshawar, Pakistan
4 shared publications - Fazia Khattak
Department of Medicine, Khyber Medical College, Peshawar, Pakistan
4 shared publications - Muhammad Abdullah Ali
Khyber Medical College Peshawar Pakistan
4 shared publications - Zaryab Bacha
Khyber Medical College, Peshawar, Pakistan
4 shared publications - Fatima Sajjad
Department of Medicine, Khyber Medical College, Peshawar, Pakistan
3 shared publications - Hira Habib
Allama Iqbal Medical College, Lahore, Pakistan
3 shared publications
Latest Publications
- 1 March 2026
- Published by Edizioni Minerva Medica in Minerva Cardiology and Angiology
- Vol. 74 (1)
Effect of vitamin D on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis
The aim of this paper was to determine whether vitamin D supplementation reduces the incidence of postoperative atrial fibrillation (POAF) in patients undergoing coronary artery bypass grafting (CABG). PubMed and Cochrane Central Register of Controlled Trials were systematically searched from inception through May 2023 for randomized controlled trials (RCTs) assessing the effectiveness of Vitamin D in preventing atrial fibrillation among postoperative patients after CABG. The primary outcome extracted was the incidence of atrial fibrillation after Vitamin D in CABG patients. Secondary outcome included the length of hospital stay. Data were pooled using a random-effect model. A total of 4 RCTs, involving 694 patients, were included in the final analysis. The results showed that Vitamin D supplementation significantly reduced the incidence of POAF in CABG patients (RR: 0.55; 95% CI: 0.40 to 0.76; P=0.0003; I2=1%). However, administration of Vitamin D did not lead to significant reduction in the length of hospital stay (WMD: -0.14; 95% CI: -0.82 to 0.53; P=0.68; I2=34%). Our updated pooled analysis concludes that vitamin D reduces the incidence of POAF in CABG patients. Future large-scale studies should focus on more diverse patient populations and explore a broader range of outcomes to better understand the full impact of Vitamin D supplementation in this context.
- 1 March 2026
- Published by Edizioni Minerva Medica in Minerva Cardiology and Angiology
- Vol. 74 (1)
Effect of vitamin D on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis
The aim of this paper was to determine whether vitamin D supplementation reduces the incidence of postoperative atrial fibrillation (POAF) in patients undergoing coronary artery bypass grafting (CABG). PubMed and Cochrane Central Register of Controlled Trials were systematically searched from inception through May 2023 for randomized controlled trials (RCTs) assessing the effectiveness of Vitamin D in preventing atrial fibrillation among postoperative patients after CABG. The primary outcome extracted was the incidence of atrial fibrillation after Vitamin D in CABG patients. Secondary outcome included the length of hospital stay. Data were pooled using a random-effect model. A total of 4 RCTs, involving 694 patients, were included in the final analysis. The results showed that Vitamin D supplementation significantly reduced the incidence of POAF in CABG patients (RR: 0.55; 95% CI: 0.40 to 0.76; P=0.0003; I2=1%). However, administration of Vitamin D did not lead to significant reduction in the length of hospital stay (WMD: -0.14; 95% CI: -0.82 to 0.53; P=0.68; I2=34%). Our updated pooled analysis concludes that vitamin D reduces the incidence of POAF in CABG patients. Future large-scale studies should focus on more diverse patient populations and explore a broader range of outcomes to better understand the full impact of Vitamin D supplementation in this context.
- 20 December 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 428
Therapeutic comparison of hypertonic saline and mannitol in pediatric intracranial hypertension: a systematic review and meta-analysis
Background Elevated intracranial pressure (ICP) in pediatric patients is a critical condition that can lead to severe complications if not managed promptly. Hypertonic saline and mannitol are both commonly used to reduce ICP, yet their comparative effectiveness remains uncertain. Despite widespread use, existing studies show mixed results, with variations in treatment protocols and patient outcomes. This uncertainty underscores the need for a clearer understanding of the most effective treatment for pediatric ICP management. Aim To compare the effectiveness of hypertonic saline and mannitol in the management of elevated intracranial pressure in pediatric patients. Methods A systematic review and meta-analysis, based on the preferred reporting items for systematic reviews and meta-analysis statements, was conducted (PROSPERO: CRD420251037689). A literature review was performed (sources: PubMed, Embase, and Cochrane Library databases; end-of-search date: April 15, 2025), and quality assessment was performed using the ROB2 and NewCastle Ottawa Scale. A random-effects model was used to pool the data for the meta-analyses. Results A total of 631 patients from five studies were included in the mortality analysis, with 367 in the HTS group and 264 in the mannitol group. The risk of mortality was not significantly different between groups (RR, 0.91; 95% CI, 0.54, 1.52; p = 0.71), with moderate heterogeneity observed (I2 = 41%). Two studies assessing ICP change at 72 h found no significant difference (mean difference: −3.79 mmHg, p = 0.46). Similarly, no significant difference was found for CPP change (mean difference: 4.55 mmHg, p = 0.36). Secondary outcomes, including ICU and hospital length of stay and mechanical ventilation duration, showed no significant differences between groups. Conclusions This meta-analysis found no significant differences in mortality, ICP, or CPP changes between the HTS and mannitol groups. Secondary outcomes, including ICU and hospital length of stay and mechanical ventilation duration, also showed no notable differences. These findings suggest that both hypertonic saline and mannitol may be similarly effective for managing elevated ICP in pediatric patients.
- 20 December 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 428
Therapeutic comparison of hypertonic saline and mannitol in pediatric intracranial hypertension: a systematic review and meta-analysis
Background Elevated intracranial pressure (ICP) in pediatric patients is a critical condition that can lead to severe complications if not managed promptly. Hypertonic saline and mannitol are both commonly used to reduce ICP, yet their comparative effectiveness remains uncertain. Despite widespread use, existing studies show mixed results, with variations in treatment protocols and patient outcomes. This uncertainty underscores the need for a clearer understanding of the most effective treatment for pediatric ICP management. Aim To compare the effectiveness of hypertonic saline and mannitol in the management of elevated intracranial pressure in pediatric patients. Methods A systematic review and meta-analysis, based on the preferred reporting items for systematic reviews and meta-analysis statements, was conducted (PROSPERO: CRD420251037689). A literature review was performed (sources: PubMed, Embase, and Cochrane Library databases; end-of-search date: April 15, 2025), and quality assessment was performed using the ROB2 and NewCastle Ottawa Scale. A random-effects model was used to pool the data for the meta-analyses. Results A total of 631 patients from five studies were included in the mortality analysis, with 367 in the HTS group and 264 in the mannitol group. The risk of mortality was not significantly different between groups (RR, 0.91; 95% CI, 0.54, 1.52; p = 0.71), with moderate heterogeneity observed (I2 = 41%). Two studies assessing ICP change at 72 h found no significant difference (mean difference: −3.79 mmHg, p = 0.46). Similarly, no significant difference was found for CPP change (mean difference: 4.55 mmHg, p = 0.36). Secondary outcomes, including ICU and hospital length of stay and mechanical ventilation duration, showed no significant differences between groups. Conclusions This meta-analysis found no significant differences in mortality, ICP, or CPP changes between the HTS and mannitol groups. Secondary outcomes, including ICU and hospital length of stay and mechanical ventilation duration, also showed no notable differences. These findings suggest that both hypertonic saline and mannitol may be similarly effective for managing elevated ICP in pediatric patients.
- 15 October 2025
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 23 (4) , 1-18
Hyperthermic Intraperitoneal Chemotherapy + Surgery Versus Surgery Alone for Ovarian Cancer, a Systematic Review and Meta Analysis of RCTs
- 15 October 2025
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 23 (4) , 1-18
Hyperthermic Intraperitoneal Chemotherapy + Surgery Versus Surgery Alone for Ovarian Cancer, a Systematic Review and Meta Analysis of RCTs
- 14 October 2025
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 56 (1) , 1-17
Comparing ICG-Guided vs. Conventional Laparoscopic Lymphadenectomy in Gastric Cancer: A Systematic Review and Meta-Analysis
Background Gastric cancer remains one of the leading causes of cancer-related mortality worldwide, with surgical intervention being a critical aspect of treatment. Lymphadenectomy plays a significant role in managing gastric cancer, with the extent of lymph node removal often influencing survival outcomes. Recent advancements in laparoscopic surgery have introduced the use of indocyanine green (ICG) fluorescence guidance to improve the accuracy and effectiveness of lymphadenectomy. However, the comparative efficacy of ICG-guided laparoscopic lymphadenectomy versus conventional techniques remains a topic of ongoing investigation. Aim This study aims to evaluate the effectiveness and surgical outcomes of ICG-guided laparoscopic lymphadenectomy compared to conventional laparoscopic lymphadenectomy in patients with gastric cancer. Methods A systematic review and meta-analysis, based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statements, was conducted (PROSPERO: CRD420251039604). A literature review was performed (sources: PubMed, Embase, and Cochrane Library databases; end-of-search date: April 22, 2025) and quality assessment was performed using the ROB 2 and Newcastle–Ottawa Scale. A random-effects model was used to pool the data for the meta-analyses. Results A total of 3996 patients from ten studies were analyzed, with 1870 undergoing ICG-guided surgery and 2126 in the non-ICG group. ICG use was associated with significantly improved 1-year (RR = 1.04) and 2-year (RR = 1.09) overall survival, and a greater number of retrieved lymph nodes (MD = 6.00). While intraoperative blood loss was significantly reduced with ICG (MD = − 14.44 mL), no significant differences were observed in metastatic lymph node count, postoperative complications, operative time, or hospital stay. Conclusions ICG-guided surgery in gastric cancer is associated with improved short- and mid-term overall survival and enhanced lymph node retrieval. It also significantly reduces intraoperative blood loss without increasing postoperative complications, operative time, or hospital stay. These findings support the clinical value of ICG in improving surgical outcomes.
- 14 October 2025
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 56 (1) , 1-17
Comparing ICG-Guided vs. Conventional Laparoscopic Lymphadenectomy in Gastric Cancer: A Systematic Review and Meta-Analysis
Background Gastric cancer remains one of the leading causes of cancer-related mortality worldwide, with surgical intervention being a critical aspect of treatment. Lymphadenectomy plays a significant role in managing gastric cancer, with the extent of lymph node removal often influencing survival outcomes. Recent advancements in laparoscopic surgery have introduced the use of indocyanine green (ICG) fluorescence guidance to improve the accuracy and effectiveness of lymphadenectomy. However, the comparative efficacy of ICG-guided laparoscopic lymphadenectomy versus conventional techniques remains a topic of ongoing investigation. Aim This study aims to evaluate the effectiveness and surgical outcomes of ICG-guided laparoscopic lymphadenectomy compared to conventional laparoscopic lymphadenectomy in patients with gastric cancer. Methods A systematic review and meta-analysis, based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statements, was conducted (PROSPERO: CRD420251039604). A literature review was performed (sources: PubMed, Embase, and Cochrane Library databases; end-of-search date: April 22, 2025) and quality assessment was performed using the ROB 2 and Newcastle–Ottawa Scale. A random-effects model was used to pool the data for the meta-analyses. Results A total of 3996 patients from ten studies were analyzed, with 1870 undergoing ICG-guided surgery and 2126 in the non-ICG group. ICG use was associated with significantly improved 1-year (RR = 1.04) and 2-year (RR = 1.09) overall survival, and a greater number of retrieved lymph nodes (MD = 6.00). While intraoperative blood loss was significantly reduced with ICG (MD = − 14.44 mL), no significant differences were observed in metastatic lymph node count, postoperative complications, operative time, or hospital stay. Conclusions ICG-guided surgery in gastric cancer is associated with improved short- and mid-term overall survival and enhanced lymph node retrieval. It also significantly reduces intraoperative blood loss without increasing postoperative complications, operative time, or hospital stay. These findings support the clinical value of ICG in improving surgical outcomes.
- Open Access
- 10 September 2025
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 40 (1) , 1-17
Efficacy and safety of indocyanine green fluorescence imaging in colorectal cancer: a systematic review and meta-analysis of randomized controlled trials
Background: The primary treatment for colorectal cancer, which is very prevalent, is surgery. Anastomotic leaking poses a significant risk following surgery. Intestinal perfusion can be objectively and instantly assessed with indocyanine green fluorescence imaging, which may lower leakage rates and enhance surgical results. Methods: PubMed, Embase, and Web of Science databases were systematically searched using relevant keywords from inception until 5th of March 2025. Eight studies were included after final screening. Outcomes were reported as overall anastomotic leakage, wound infection, paralytic ileus, mechanical ileus, and post-operative hospital stay. Interstudy heterogeneity was assessed using I 2 and X 2 statistics (I 2 > 50% = significant heterogeneity). Statistical calculations were performed using Review Manager 5.4.1 (The Cochrane Collaboration, Copenhagen, Denmark), with a p-value of < 0.05 indicating statistical significance. Results: This meta-analysis includes 4047 patients from eight investigations (2026 indocyanine green (ICG) group, 2021 non-ICG group). Overall anastomotic leak risk was considerably decreased with ICG use (risk ratio (RR) = 0.66; 95% CI: 0.54–0.81; p < 0.0001) and showed no heterogeneity (I 2 = 0%). There was no heterogeneity (I 2 = 0%) in the Grade A leakage occurrence, which was considerably lower in the ICG group (RR = 0.34; 95% CI: 0.16–0.72; p = 0.005). With little heterogeneity (I 2 = 8.6%), combined leakage grades also supported ICG use (RR = 0.54; 95% CI: 0.35–0.84; p = 0.006). ICG was associated with a substantial decrease in Clavien–Dindo Grade I complications (RR = 0.67; 95% CI: 0.49–0.92; p = 0.01) without heterogeneity (I 2 = 0%). Initial postoperative hospital stays, mechanical ileus, paralytic ileus, and abdominal bleeding did not differ significantly. Although there was no heterogeneity (I 2 = 0%), sensitivity analysis showed that the ICG group had a substantially longer postoperative stay (MD = 0.27; 95% CI 0.05–0.49; p = 0.02) and significantly fewer wound infections (RR = 0.17; 95% CI 0.04–0.76; p = 0.02). With noteworthy heterogeneity (I 2 = 70%), the ICG group’s operating time was significantly longer (MD = 8.26 min; 95% CI 0.52–16.00; p = 0.04). Conclusion: Although indocyanine green fluorescence imaging may marginally lengthen the recovery period and duration of operation, it dramatically lowers anastomotic leakage and wound infections following colorectal surgery, enhancing results.
- 10 September 2025
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 40 (1) , 1-17
Open AccessEfficacy and safety of indocyanine green fluorescence imaging in colorectal cancer: a systematic review and meta-analysis of randomized controlled trials
Background: The primary treatment for colorectal cancer, which is very prevalent, is surgery. Anastomotic leaking poses a significant risk following surgery. Intestinal perfusion can be objectively and instantly assessed with indocyanine green fluorescence imaging, which may lower leakage rates and enhance surgical results. Methods: PubMed, Embase, and Web of Science databases were systematically searched using relevant keywords from inception until 5th of March 2025. Eight studies were included after final screening. Outcomes were reported as overall anastomotic leakage, wound infection, paralytic ileus, mechanical ileus, and post-operative hospital stay. Interstudy heterogeneity was assessed using I 2 and X 2 statistics (I 2 > 50% = significant heterogeneity). Statistical calculations were performed using Review Manager 5.4.1 (The Cochrane Collaboration, Copenhagen, Denmark), with a p-value of < 0.05 indicating statistical significance. Results: This meta-analysis includes 4047 patients from eight investigations (2026 indocyanine green (ICG) group, 2021 non-ICG group). Overall anastomotic leak risk was considerably decreased with ICG use (risk ratio (RR) = 0.66; 95% CI: 0.54–0.81; p < 0.0001) and showed no heterogeneity (I 2 = 0%). There was no heterogeneity (I 2 = 0%) in the Grade A leakage occurrence, which was considerably lower in the ICG group (RR = 0.34; 95% CI: 0.16–0.72; p = 0.005). With little heterogeneity (I 2 = 8.6%), combined leakage grades also supported ICG use (RR = 0.54; 95% CI: 0.35–0.84; p = 0.006). ICG was associated with a substantial decrease in Clavien–Dindo Grade I complications (RR = 0.67; 95% CI: 0.49–0.92; p = 0.01) without heterogeneity (I 2 = 0%). Initial postoperative hospital stays, mechanical ileus, paralytic ileus, and abdominal bleeding did not differ significantly. Although there was no heterogeneity (I 2 = 0%), sensitivity analysis showed that the ICG group had a substantially longer postoperative stay (MD = 0.27; 95% CI 0.05–0.49; p = 0.02) and significantly fewer wound infections (RR = 0.17; 95% CI 0.04–0.76; p = 0.02). With noteworthy heterogeneity (I 2 = 70%), the ICG group’s operating time was significantly longer (MD = 8.26 min; 95% CI 0.52–16.00; p = 0.04). Conclusion: Although indocyanine green fluorescence imaging may marginally lengthen the recovery period and duration of operation, it dramatically lowers anastomotic leakage and wound infections following colorectal surgery, enhancing results.